Supreme Court Delivers Landmark Ruling in Purdue Pharma Bankruptcy, Shaping Future of Mass Tort Cases
WASHINGTON — A recent Supreme Court decision has resoundingly reshaped the landscape of bankruptcy law, particularly in how it pertains to mass tort litigations, exemplified by the high-profile Purdue Pharma bankruptcy case. At the heart of this judicial review was a debated proposal to exempt the Sackler family — owners of Purdue Pharma and makers of OxyContin — from future civil lawsuits while committing them to pay $6 billion into a settlement fund for victims of the opioid crisis. Purdue Pharma entered into bankruptcy in 2019 after facing a slew of lawsuits that attributed much … Read more